Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03775967
Other study ID # UGD-H-18-10-31-10
Secondary ID
Status Completed
Phase
First received
Last updated
Start date October 10, 2018
Est. completion date February 10, 2019

Study information

Verified date November 2019
Source Ajman University
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Sialic acid (SA) is the generic term given to a family of acetylated derivatives of neuraminic acid. SA is a 9 carbon monosaccharide. An important function of host SA is to regulate innate immunity. SA is present in several acute phase proteins which are known to be associated with periodontitis. There exists a need for a biomarker, for early detection of disease evolution and more robust therapy efficacy measurements. Till date, there is very little data regarding simultaneous estimation and comparison of total SA content in saliva. IL-10, an anti-inflammatory cytokine, regulates the synthesis of pro-inflammatory cytokines such as IL-1, -2, -6 and stimulates protective antibody production. IL-10 is expressed in both healthy and diseased human periodontal tissues and is reported to be reduced in patients infected with Aggregatibacter actinomycetemcomitans.

The present study was therefore undertaken with an aim, to not only assess the levels of TSA(Total sialic acid levels),but also of IL 10 levels in saliva from stage 1(mild) to stage 2(moderate) periodontitis patients


Description:

Selection of patients by grading the patients according to criteria stage 1 and 2 Periodontitis

Obtaining consent from patients participating in the study

Collection of saliva-unstimulated whole saliva, the samples will be stored at -20 degree Centigrade and later placed in a 1.5ml centrifuge tubes which will be placed in a vacuum cool box indicated for laboratory samples and transported to the lab for investigations. It will be centrifuged at 2500 rpm for 10 mins,stored at -80 deg C. SA(sialic acid) levels will be determined by thiobarbutic acid method of aminoff and ELISA methods. SA levels will be measured in mg/dl,IL10 as in direct measurement.


Recruitment information / eligibility

Status Completed
Enrollment 60
Est. completion date February 10, 2019
Est. primary completion date January 10, 2019
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 55 Years
Eligibility Inclusion Criteria:

- All the subjects should be within the age group of 18 to 55 years

- subject should have atleast 18 natural teeth excluding third molars.

Exclusion Criteria:

- History of periodontal debridement or periodontal surgery in preceding six months or any antimicrobial therapy, anti-inflammatory drugs.

- corticosteroids, in previous three months

- systemically compromised individuals

- smokers

- pregnant and lactating women

- Medical history for absence of systemic disorders such as diabetes mellitus

- cardiovascular diseases

- pneumonia

- tuberculosis

- rheumatoid arthritis

Study Design


Related Conditions & MeSH terms


Intervention

Diagnostic Test:
sialic acid
sialic acid level estimation in salivary samples
IL10
IL10 estimation in salivary samples

Locations

Country Name City State
India AB shetty institute of dental sciences Mangalore

Sponsors (1)

Lead Sponsor Collaborator
Ajman University

Country where clinical trial is conducted

India, 

Outcome

Type Measure Description Time frame Safety issue
Primary Sialic acid levels in stage 1 periodontitis Sialic acid is measured by taking salivary samples(unstimulated) from stage 1 periodontitis patients From baseline to 3 months
Primary Sialic acid levels in stage 2 periodontitis Sialic acid is measured by taking salivary samples(unstimulated) from stage 2 periodontitis patients From baseline to 3 months
Primary IL10 levels in stage 1 periodontitis IL10 is measured by taking salivary samples(unstimulated) from stage 1 periodontitis patients From baseline to 3 months
Primary IL10 levels in stage 2 periodontitis IL10 is measured by taking salivary samples(unstimulated) from stage 2 periodontitis patients From baseline to 3 months
See also
  Status Clinical Trial Phase
Completed NCT02618486 - The Effects of Obesity on Non Surgical Periodontal Therapy N/A
Recruiting NCT01785355 - The Impact Of Periodontal Disease Treatment On The General Health Status In Chronic Haemodialyzed Patients
Completed NCT01639183 - Power Toothbrush Use in Nursing Homes to Eliminate Mouth and Body Inflammation N/A
Completed NCT02935322 - Interaction Between Chlorhexidine and Fluoride Phase 4
Completed NCT00093236 - Impact of Gum Infection on Heart Disease N/A
Completed NCT03444363 - Periodontal Treatment With Diode Laser in the Patients With Diabetes Melitus N/A
Completed NCT03641989 - Correlation Between Oral Health and Systemic Inflammation (COHESION) N/A
Withdrawn NCT02202304 - The Effects of Chlorhexidine/Thymol Varnish on Partial Denture Patient Phase 4
Recruiting NCT01568697 - Oral Bacteria and Immune System Problems Involved in Gum Disease (Periodontitis)
Completed NCT04873505 - Functional Validation of Lactobacillus Containing Oral Tablet N/A
Completed NCT01521260 - Implant Surface Decontamination in Peri-implantitis Treatment N/A
Recruiting NCT00553007 - The Relation Between Periodontal Disease and Metabolic Syndrome N/A
Completed NCT01399034 - Epigenetics, DNA Methylation Patterns and Periodontal Disease N/A
Recruiting NCT00162838 - Effects of Periodontal Pathogens, Porphyromonas Gingivalis and Tannerella Forsythensis, on Cytokine Production From Human Monocyte-Derived Dendritic Cells N/A
Completed NCT00016835 - Treating Periodontal Infection: Effects on Glycemic Phase 2
Completed NCT03540498 - Study of Colonization of Strains L.Plantarum and L.Brevis in the Product AB-DENTALAC Chewing Gum N/A
Completed NCT02914743 - Providing Preventive Periodontal Treatment to Hospitalized Patients With Diabetes N/A
Completed NCT02894463 - Study Aimed at Detecting Potential Abuse of Nitrous Oxide in Children During Dental Care N/A
Completed NCT02289066 - Impact of Periodontal Disease on Outcomes in Diabetes N/A
Not yet recruiting NCT01718912 - Periodontal Disease Treatment of a Physically Challenged Population N/A